Hartline Investment Corp’s Eli Lilly LLY Stock Holding History

Hartline Investment Corp’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.3M	Buy	14,494 +734	+5%	+$744K	1.47%	19
2025 Q4	$14.8M	Sell	13,760 -3,485	-20%	-$3.33M	1.6%	15
2025 Q3	$13.2M	Buy	17,245 +296	+2%	+$220K	1.36%	18
2025 Q2	$13.2M	Buy	16,949 +2,761	+19%	+$2.15M	1.5%	18
2025 Q1	$11.7M	Sell	14,188 -1,329	-9%	-$1.11M	1.56%	17
2024 Q4	$12M	Sell	15,517 -11,441	-42%	-$9.47M	1.37%	19
2024 Q3	$23.9M	Buy	26,958 +6,818	+34%	+$6.13M	2.98%	10
2024 Q2	$18.2M	Buy	20,140 +14,181	+238%	+$11.3M	2.45%	12
2024 Q1	$4.64M	Sell	5,959 -15,975	-73%	-$11.4M	0.82%	23
2023 Q4	$12.8M	Buy	21,934 +248	+1%	+$145K	2.07%	13
2023 Q3	$11.6M	Sell	21,686 -984	-4%	-$507K	2.09%	12
2023 Q2	$10.6M	Buy	22,670 +454	+2%	+$190K	1.81%	15
2023 Q1	$7.63M	Buy	22,216 +1,580	+8%	+$533K	1.52%	17
2022 Q4	$7.55M	Buy	20,636 +19,104	+1,247%	+$6.77M	1.72%	15
2022 Q3	$495K	Buy	+1,532	New	+$485K	0.41%	51

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Hartline Investment Corp's LLY Position: Q1 2026 in Review

Hartline Investment Corp increased its Eli Lilly (LLY) stake by 5.3% in Q1 2026, buying an estimated $744K and bringing the position to 14,494 shares worth $13.3M. The position accounts for 1.47% of the portfolio, ranked #19.

Hartline Investment Corp first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $23.9M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Hartline Investment Corp held 14,494 shares of Eli Lilly worth $13.3M as of Q1 2026.
Hartline Investment Corp bought 734 Eli Lilly shares in Q1 2026, an estimated $744K.
Eli Lilly made up 1.47% of Hartline Investment Corp's portfolio in Q1 2026, its #19 holding.
Hartline Investment Corp first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
Hartline Investment Corp's Eli Lilly position peaked at $23.9M in Q3 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hartline Investment Corp's 13F filing for Q1 2026, filed 29 Apr 2026.